The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. After-hours trades for IQVIA Holdings Inc (IQV) shows that investor sentiment remained same, with the stock’s consolidated last price to $200.08. The IQVIA Holdings Inc has recorded 54,402 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that IQVIA’s Christina Mack Named 2023 PharmaVoice 100 Honoree.
The company is listed on the NYSE and operates within the Diagnostics & Research industry segment. At the end of the last regular session, the stock closed at $200.08 and fluctuated between $201.39 as its day high and $196.35 as its day low. The current market capitalization of IQVIA Holdings Inc is $36.51B. A total of 1.6 million shares were traded on the day, compared to an average of 1.19M shares.
Furthermore, investors take into consideration insider trades when predicting a stock’s future trajectory. During the recent three months, IQV has seen 4 BUY and 3 SELL insider trades, representing the acquisition of 26,186 and the disposition of 46,084 shares. Over the last 12 months, there were 15 BUYs and 28 SELLs from insiders. Insiders purchased 140,031 shares during that period but sold 125,279.
In the most recent transaction, Panagos Constantinos sold 27,317 shares of IQV for 208.67 per share on Sep 19. After the transaction, the insider now owns 14,250 company shares. In a previous transaction on Jun 05, Knightly Kevin C sold 5,820 shares at 201.89 per share. IQV shares that the insider owns now total 0.
Among the insiders who sold shares, Knightly Kevin C disposed of 1 shares on May 26 at a per-share price of $198.66. This resulted in the insider holding 0 shares of IQV after the transaction. In another insider transaction, Knightly Kevin C sold 4,446 shares at $225.61 per share on Feb 16. Company shares held by the insider now total 1,973.
It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. According to analysts who have offered 12-month price targets for IQV in the last 3 months, the mean price target is $225.74 with high estimates of $262.00 and low estimates of $190.00. In terms of 52-week highs and lows, IQV has a high of $241.86 and a low of $167.42.
As of this writing, IQV has an earnings estimate of $2.44 per share for the current quarter. EPS was calculated based on a consensus of 18 estimates, with a high estimate of $2.49 per share and a lower estimate of $2.35. The company reported an EPS of $2.45 in the last quarter, which was 1.70% higher than expectations of $2.41.
Balance Sheet Annually/Quarterly
An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. IQV’s latest balance sheet shows that the firm has $1.48B in Cash & Short Term Investments as of fiscal 2021. There were $12.44B in debt and $5.24B in liabilities at the time. Its Book Value Per Share was $31.81, while its Total Shareholder’s Equity was $6.04B.
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IQV is Buy with a score of 4.53.